SYCP3 is overexpressed in various human breast cancer cell lines, and EMSY is amplified almost exclusively in sporadic breast and ovarian cancers32,33, suggesting that overexpression of SYCP3 and EMSY phenocopies cancer related-BRCA2 mutations. This evidence concerns the gene BRCA2 and breast carcinoma.